Alternatives to ANI

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

AI-driven digital twin of embryo development for cell-based therapies.

AI-guided drug discovery platform for tissue-targeted medicines.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered platform for designing novel molecular structures for new medicines.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Develops antibody-drug conjugates (ADCs) for targeted cancer therapy.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Omnix Medical is developing a novel platform for advanced wound care management.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

A global contract research organization specializing in preclinical and translational oncology research.

Engineering scalable gene therapies for broader patient populations.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Pioneering vision restoration therapies for severe retinal degenerations.

AI-powered antibody discovery platform.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Digital infrastructure for manufacturing to boost efficiency and reduce costs.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Scalable, one-time curative in-vivo gene editing therapies.

Develops and manufactures biologics for therapeutic applications.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.

Developing novel therapeutics for challenging diseases using advanced biological insights.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Global automotive manufacturer producing a wide range of vehicles, including cars, trucks, and SUVs.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

Bio-pharmaceutical company developing novel, biologically sourced therapies for animal and human health.